Articles
Latest Articles
Commentaries
Deals
Distillery
Emerging Companies
Finance
Politics, Policy & Law
Product Development
Regulation
Targets & Mechanisms
Tools & Techniques
Full Editions
BIOCENTURY
BIOCENTURY INNOVATIONS
BIOCENTURY EXTRA
BIOCENTURY WEEK IN REVIEW
Search Archives
BCIQ
Company Profiles
Target Profiles
Product Profiles
Conferences
China Healthcare Summit
Bio€quity Europe
Future Leaders
NewsMakers
White Papers
Free Trial
/
Subscribe
Sign In
more_vert
Biocentury
search
Previous
article
Back
to Feed
Next
article
Share
Text Size
A
A
A
Print
BGM Galectin-3 heart failure risk test regulatory update
By WIR Staff | May 21, 2012 | 7:00 AM GMT
BG Medicine received CE Mark approval to expand the indication for its BGM
Read the full
130
word article
User Sign In
Previous
article
Back
to Feed
Next
article
JavaScript is necessary to work with this application.